You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠集團AH股盤中均漲超6% V-01序貫加強III期臨牀中期數據積極
格隆匯2月17日丨麗珠集團(000513.SZ)一度漲近7%報40元,麗珠醫藥(1513.HK)一度漲6.69%報30.3港元。國盛證券今日發佈研報稱,維持麗珠集團(000513.SZ)買入評級。評級理由主要包括:1)佐劑-抗原一體化設計,V-01打開高效抗疫新思路;2)序貫加強方案保護力顯示優效性,對Omicron保護效果良好;3)V-01免疫原性優、使用安全,早期臨牀數據亮眼;4)V-01在新冠疫苗重組蛋白技術路線具先發優勢,海內外應用市場空間廣闊;5)物料國產化、供應持續穩定,V-01將為我國疫情防控提供有力支撐。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account